RxDoctor Payments Data

Lorenzo Ray Lim, DO

Family Medicine · Southfield, MINPI 1194104885

Payments from drug & device makers

$1,523in general payments, 2019–2025

Across 90 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$306
  • Lilly USA, LLC$259
  • Dexcom, Inc.$151
  • Boehringer Ingelheim$113
  • Novartis$110
  • Exact Sciences$90
  • plus $494 from 16 others

What the payments were for

  • Food & beverage$1,523100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,523 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$39,527
Medicare patients
95
Services billed
473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban71$79,200
MounjaroTirzepatide58$66,457
JardianceEmpagliflozin53$62,448
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$35,538
OzempicSemaglutide18$20,269
XareltoRivaroxaban24$17,431
Synjardy XrEmpagliflozin/Metformin Hcl15$6,165
Atorvastatin Calcium331$4,430
Amlodipine-ValsartanAmlodipine Besylate/Valsartan32$3,370
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$3,366
Sucralfate12$2,995
Losartan Potassium182$2,812
Albuterol Sulfate HfaAlbuterol Sulfate66$2,422
Amlodipine Besylate327$2,400
Ventolin HfaAlbuterol Sulfate27$2,245

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$30$79,20071 claims
Boehringer IngelheimJardiance, Synjardy Xr$113$68,61468 claims
Lilly USA, LLCMounjaro$259$66,45758 claims
GSKTrelegy Ellipta$76$35,53849 claims
Novo NordiskOzempic$306$20,26918 claims
Johnson & JohnsonXarelto$14$17,43124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Southfield

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →